A comparison study of Dutch and Norwegian Myasthenia Gravis patients: epidemiological and clinical aspects.

Completed

• Conditions: muscle disease; serious muscle weakness; 10029317

• Registration Number: NL-OMON35739
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

criteria 1 and 2 or 1 and 3 have to be fulfilled
1. Clinical weakness compatible with a from of myasthenia
2. Electromyographic evicence consistent with a neuromuscular transmission defect
3. Elevated serum antibody levels against ACHR, MuSK or VGCC

Exclusion Criteria

Age of < 18 years
Lack of both criteria 2 and 3

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study parameters/endpoints:<br /><br>Primary endpoint: Comparison of potential predisposing and modifying factors<br /><br>between Dutch and Norwegian MG patients.<br /><br><br /><br>.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoint: Comparison of demography, quality of life and differences<br /><br>in medical treatment between Dutch MG patients and Norwegian MG patients</p><br>